Trials / Not Yet Recruiting
Not Yet RecruitingNCT06441539
Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions
Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions: a Prospective, Multi-center, Randomized, Non-inferiority Trial
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 218 (estimated)
- Sponsor
- Yinyi(Liaoning) Biotech Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Bingo drug-eluting balloon versus a drug-eluting stent for coronary bifurcation lesions: a prospective, multi-center, randomized, non-inferiority trial
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Bingo® Paclitaxel coated balloon | Treat the main vessel and side branch of bifurcation lesion with drug-eluting balloon |
| DEVICE | Xience® Alpine Everolimus Eluting Coronary Stent System | Treat the main vessel of bifurcation lesion with drug-eluting stent, and treat the side branch with uncoated balloon or drug-eluting stent |
Timeline
- Start date
- 2024-07-01
- Primary completion
- 2025-02-28
- Completion
- 2026-05-31
- First posted
- 2024-06-04
- Last updated
- 2024-06-04
Source: ClinicalTrials.gov record NCT06441539. Inclusion in this directory is not an endorsement.